Breast Neoplasms: all 12,820 studies
Page 29 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)RecruitingNCT03711110Not applicable
- Liquid Biopsy Evaluation and Repository Development at Princess MargaretRecruitingNCT03702309
- TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast CancerRecruitingNCT03694756Not applicable
- Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative ChemotherapyNot yet recruitingNCT03684863Phase 2
- A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer PatientsRecruitingNCT03671044Phase 3
- Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene MutationRecruitingNCT03667417
- Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)RecruitingNCT03664895Phase 3
- SEMA4C as a Relapse Biomarker in Breast CancerNot yet recruitingNCT03663153
- A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast CancerRecruitingNCT03655353Not applicable
- The Value of Geriatric Assessments in Older Patients With Breast CancerRecruitingNCT03640117
- Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTFRecruitingNCT03604315Phase 1
- Southeast Netherlands Advanced Metastatic Breast Cancer RegistryRecruitingNCT03577197
- Talking to Employers and Medical Staff About Breast Cancer Treatment and Your JobRecruitingNCT03572374Not applicable
- A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTientsRecruitingNCT03561740Phase 3
- Genetic Education in BRCA FamiliesEnrolling by invitationNCT03544983Not applicable
- 12-week Exercise Intervention Program Versus Observation in Early Stage Breast Cancer Patients on the Impact on Mental Health, Quality of Life and Immune MarkersRecruitingNCT03518957Phase 3
- Plasmodium Immunotherapy for Breast and Liver CancersRecruitingNCT03474822Phase 1/2
- Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast TumorsRecruitingNCT03463954Not applicable
- Database of Data CollectionRecruitingNCT03461172
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Older Breast Cancer Patients: Risk for Cognitive DeclineRecruitingNCT03451383
- Development of Clinical and Biological DatabaseRecruitingNCT03449264Not applicable
- Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer PatientsRecruitingNCT03449238Phase 1/2
- Identification of New Prognostic Markers for Breast Cancer.RecruitingNCT03436069
- Optimized Rehabilitation Following Primary Breast Cancer SurgeryRecruitingNCT03434717Not applicable
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerRecruitingNCT03424005Phase 1/2
- S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityRecruitingNCT03418961Phase 3
- Wide Margin vs. Narrow Margin in Postneoadjuvant LumpectomyRecruitingNCT03417622Phase 3
- Breast Cancer Registry PlatformRecruitingNCT03417115
- Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic CancerRecruitingNCT03412877Phase 2
- Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT StudyRecruitingNCT03408353
- PET-MRI for Axillary Staging in Node Negative Breast Cancer PatientsRecruitingNCT03374826Not applicable
- Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast CancerRecruitingNCT03351062Phase 3
- Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy EffectivenessRecruitingNCT03321045Early Phase 1
- Adaptations to Breast Cancer and ExerciseRecruitingNCT03314168Not applicable
- Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008RecruitingNCT03275311
- Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall ResectionRecruitingNCT03265379
- Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast CancerRecruitingNCT03260192
- Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast CancerRecruitingNCT03213925Phase 2
- Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk WomenRecruitingNCT03201861Phase 3
- Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast CancerRecruitingNCT03150576Phase 2/3
- PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American WomenRecruitingNCT03144648
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruitingNCT03053193
- Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors TrialRecruitingNCT03011684Phase 3
- Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast CancerRecruitingNCT02992574Not applicable
- Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyRecruitingNCT02945579Not applicable
- Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast CancerRecruitingNCT02926690Phase 1
- Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young WomenRecruitingNCT02914158Phase 3
- Ontario-wide Cancer TArgeted Nucleic Acid EvaluationRecruitingNCT02906943
- A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of BreastRecruitingNCT02897700Phase 1
- PREgnancy and FERtility RegistryRecruitingNCT02895165
- Bergonie Institute Breast Cancer DatabaseRecruitingNCT02893761
- Prospective and Retrospective Breast Cancer DatabaseRecruitingNCT02884284
- Institut Paoli Calmettes Breast Cancer DatabaseRecruitingNCT02869607
- Utrecht Cohort for Multiple Breast Cancer Intervention Studies and Long-term Evaluation - The UMBRELLA CohortRecruitingNCT02839863
- Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing CancersRecruitingNCT02830724Phase 1/2
- A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)RecruitingNCT02819882
- Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.Not yet recruitingNCT02802423Phase 1/2
- Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer PatientsRecruitingNCT02772367
- Lymphedema Surveillance StudyRecruitingNCT02743858
- Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching HostRecruitingNCT02732860
- PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast CancerRecruitingNCT02732171Not applicable
- A Registry Study of Breast Microseed TreatmentRecruitingNCT02701244
- Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryRecruitingNCT02627248Phase 4
- Women Informed to Screen Depending on Measures of Risk (Wisdom Study)RecruitingNCT02620852Not applicable
- Huaier Granule in Treating Women With Triple Negative Breast CancerRecruitingNCT02615457Phase 4
- Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast CancerRecruitingNCT02610439
- Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast CancerRecruitingNCT02610426
- Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast CancerRecruitingNCT02610413
- Genomic Services Research ProgramRecruitingNCT02595957
- Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast CancerRecruitingNCT02541435
- Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast CancerRecruitingNCT02535221Phase 3
- Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast CancerRecruitingNCT02506361
- Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence ScoreRecruitingNCT02476786Phase 2
- PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line ChemotherapyNot yet recruitingNCT02448576Not applicable
- Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal MetastasisRecruitingNCT02422641Phase 2
- Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast CancerRecruitingNCT02389673Not applicable
- Praegnant Breast Cancer: Early/Advanced/MetastaticRecruitingNCT02338167
- Cancer Experience Registry (CER) for Cancer Patients and CaregiversRecruitingNCT02333604
- Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast CancerRecruitingNCT02306096
- Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier RegistryRecruitingNCT02302742
- Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast CancerRecruitingNCT02290834Not applicable
- Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of TreatmentsRecruitingNCT02284581
- Core Biopsies for Establishing a Breast Tumor Tissue RepositoryRecruitingNCT02250352
- AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.RecruitingNCT02102165Not applicable
- Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer PatientsRecruitingNCT02062489Phase 3
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- The Cancer of the Pancreas Screening-5 CAPS5)StudyRecruitingNCT02000089Phase 3
- Chronic Toxicities Related to Treatment in Patients With Localized CancerRecruitingNCT01993498Not applicable
- Breast Cancer Proteomics and Molecular HeterogeneityRecruitingNCT01840293
- ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI and Eagle Imaging DevicesRecruitingNCT01837225
- Establishment of a Tumor Bank for Tissue SamplesRecruitingNCT01789229
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and LymphomaRecruitingNCT01788839
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerRecruitingNCT01766297Phase 2
- Establishment of a Tumor Bank for Blood SamplesRecruitingNCT01763125
- A Study of Genetic Based Chemotherapy Dosing for Breast Cancer PatientsRecruitingNCT01740271Phase 2
- Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer PatientsRecruitingNCT01530373Phase 2
- Prospective Screening for Breast Cancer-related LymphedemaRecruitingNCT01521741
- The Immune System's Response to Young Women's Breast CancerRecruitingNCT01503190
- Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisRecruitingNCT01441089